» Articles » PMID: 23910564

Inflammation in the Context of Oral Cancer

Overview
Journal Oral Oncol
Publisher Elsevier
Specialty Dentistry
Date 2013 Aug 6
PMID 23910564
Citations 82
Authors
Affiliations
Soon will be listed here.
Abstract

The link between cancer and inflammation is specific transcription factors that once activated have the capacity to enhance expression of genes that are common to both the regulation and the production of mediators of inflammation, and also to the regulation of the survival and proliferation of cancer cells. Cellular pathways activated by chronic inflammation brought about by chronic infections, by immune-mediated diseases, or by dysregulated wound healing at sites of repetitive tissue injury, constitute risk factors for initial cell transformation and for cancer progression. In established cancers, the cancer cells induce development of an exaggerated inflammatory state in the stroma, which in turn promotes cancer growth, invasion and metastasis. Inflammatory cells of myeloid origin in the tumour-associated stroma, mediate suppression of immune responses against cancer cells, which suppression favours tumour growth. Oral submucous fibrosis, and to a lesser extent oral lichen planus are precancerous conditions in which immuno-inflammatory processes are implicated in their pathogenesis, and in their cancerous transformation, if it occurs. Although there is some evidence for an association between oral squamous cell carcinoma on the one hand and dento-gingival bacterial plaques and chronic periodontitis on the other hand, the role of inflammation as the sole cause of cancerous transformation in such cases is not proven. The purpose of this article is to elaborate on some of the more important relationships between oral cancer and inflammation, and to comment on the role of inflammation in the pathogenesis of oral squamous cell carcinoma.

Citing Articles

Clinical Management Update of Oral Leukoplakia: A Review From the American Head and Neck Society Cancer Prevention Service.

Gates J, Abouyared M, Shnayder Y, Farwell D, Day A, Alawi F Head Neck. 2024; 47(2):733-741.

PMID: 39584361 PMC: 11717973. DOI: 10.1002/hed.28013.


Prognostic value of systemic immune-inflammation index and systemic inflammation response index for oral cancers: A systematic review and meta-analysis.

Yang S, Fei C Med Oral Patol Oral Cir Bucal. 2024; 29(6):e822-e831.

PMID: 39396135 PMC: 11584967. DOI: 10.4317/medoral.26779.


Co-Culture of . and . Synergistically Elevates IL-6 Expression via TLR4 Signaling in Oral Keratinocytes.

Yanez L, Soto C, Tapia H, Pacheco M, Tapia J, Osses G Int J Mol Sci. 2024; 25(7).

PMID: 38612423 PMC: 11011619. DOI: 10.3390/ijms25073611.


An Overview of the Dichotomous Role of Microbiota in Cancer Progression and Management.

Jain P, Mohapatra S, Farooq U, Hassan N, Aamir Mirza M, Iqbal Z Curr Cancer Drug Targets. 2024; 25(1):38-48.

PMID: 38409691 DOI: 10.2174/0115680096282503240124104029.


Arecoline Induces ROS Accumulation, Transcription of Proinflammatory Factors, and Expression of KRT6 in Oral Epithelial Cells.

Wang T, Shen Y, Chen H, Chen C, Lin N, Shih Y Biomedicines. 2024; 12(2).

PMID: 38398015 PMC: 10887121. DOI: 10.3390/biomedicines12020412.